Literature DB >> 7992912

Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events.

V Chapman1, J E Haley, A H Dickenson.   

Abstract

BACKGROUND: Spinal N-methyl-D-aspartate (NMDA) receptor-mediated mechanisms may contribute to reduced opioid sensitivity in conditions of pain. The effectiveness of spinal opioids in inhibiting NMDA-mediated nociceptive events was assessed with two models. In addition, opioid dose-response curves with preemptive administration were compared with early and late postadministrations.
METHODS: Dorsal horn nociceptive neuronal responses were recorded in the intact halothane anesthetized rat to acute repetitive C-fiber electrical stimulation (0.1 and 0.5 Hz) and to the peripheral injection of 5% formalin. At 0.5 Hz but not at 0.1 Hz, there was an enhanced C-fiber evoked response of dorsal horn neurons elicited by repetitive C-fiber stimulation (wind-up), which is mediated by the NMDA receptor. Formalin produced a biphasic response; the late protracted inflammatory phase was NMDA receptor-mediated.
RESULTS: With 0.5-Hz stimulation a large degree of wind-up was elicited; it was less sensitive to 5 micrograms morphine compared with the effect of the same dose on the residual wind-up elicited at 0.1 Hz. Preadministration and early postadministration of morphine were equieffective at inhibiting the second-phase formalin response. In contrast, administration of the fast-acting mu opioid, D-Ala-Gly-MePHe-Gly-ol, given late postadministration (during the second phase) was less effective than preadministration. Increasing the dose of D-Ala-Gly-MePHe-Gly-ol produced complete inhibitions.
CONCLUSIONS: NMDA receptor-mediated neuronal responses, such as wind-up and the established second phase of the formalin response, are poorly responsive to opioids. Dose increases and preemptive opioids effectively inhibit these NMDA receptor-mediated events.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7992912     DOI: 10.1097/00000542-199412000-00018

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat.

Authors:  V Chapman
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Ana Vicente-Sánchez; Esther Berrocoso; Javier Garzón
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

3.  Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo.

Authors:  L C Stanfa; V Chapman; N Kerr; A H Dickenson
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Ana Vicente-Sánchez; Concha Bailón; Beatriz Martín-Aznar; Javier Garzón
Journal:  Cell Mol Life Sci       Date:  2010-12-14       Impact factor: 9.261

Review 5.  Peripheral and central sensitization in fibromyalgia: pathogenetic role.

Authors:  Roland Staud; Michael L Smitherman
Journal:  Curr Pain Headache Rep       Date:  2002-08

6.  The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders.

Authors:  María Rodríguez-Muñoz; Elsa Cortés-Montero; Andrea Pozo-Rodrigálvarez; Pilar Sánchez-Blázquez; Javier Garzón-Niño
Journal:  Oncotarget       Date:  2015-11-03

Review 7.  Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Manuel Merlos; Javier Garzón-Niño
Journal:  Oncotarget       Date:  2016-08-23

8.  HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity.

Authors:  Ana Vicente-Sánchez; Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Javier Garzón
Journal:  Mol Brain       Date:  2013-10-05       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.